{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:01:33Z","timestamp":1772190093403,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-04714-4","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:06:24Z","timestamp":1768457184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of TNF-\u03b1 (\u2212\u2009308G>A and \u2212\u2009857 C>T) promoter variants on susceptibility to chronic hepatitis B virus infection in a cohort of Mauritanian patients: pilot study"],"prefix":"10.1186","volume":"26","author":[{"given":"Saffiya Mounira","family":"Ennahoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdallah Sid","family":"M\u2019Hamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatimetou","family":"Veten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidi M.","family":"Cheikh Bouna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelhamid","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1797-824X","authenticated-orcid":false,"given":"Tetou","family":"Soumbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Houmeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"4714_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100623","volume":"5","author":"T Mitchell","year":"2023","unstructured":"Mitchell T, Nayagam JS, Dusheiko G, Agarwal K. Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries. JHEP Rep. 2023;5:100623. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100623.","journal-title":"JHEP Rep"},{"key":"4714_CR2","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"BS Sheena","year":"2022","unstructured":"Sheena BS, Hiebert L, Han H, Ippolito H, Abbasi-Kangevari M, Abbasi-Kangevari Z, et al. Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7:796\u2013829. https:\/\/doi.org\/10.1016\/S2468-1253(22)00124-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4714_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ijid.2023.02.006","volume":"129","author":"G Brancaccio","year":"2023","unstructured":"Brancaccio G, Coco B, Nardi A, Quaranta MG, Tosti ME, Ferrigno L, et al. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: clues from the nationwide PITER and MASTER cohorts toward elimination. Int J Infect Dis. 2023;129:266\u201373. https:\/\/doi.org\/10.1016\/j.ijid.2023.02.006.","journal-title":"Int J Infect Dis"},{"key":"4714_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/cid\/ciy598","volume":"68","author":"D Bixler","year":"2019","unstructured":"Bixler D, Zhong Y, Ly KN, Moorman AC, Spradling PR, Teshale EH, et al. Mortality among patients with chronic hepatitis B infection: the chronic hepatitis cohort study (CHeCS). Clin Infect Dis. 2019;68:956\u201363. https:\/\/doi.org\/10.1093\/cid\/ciy598.","journal-title":"Clin Infect Dis"},{"key":"4714_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-2893.2009.01117.x","volume":"16","author":"VTT Nguyen","year":"2009","unstructured":"Nguyen VTT, Law MG, Dore GJ. Hepatitis b-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat. 2009;16:453\u201363. https:\/\/doi.org\/10.1111\/j.1365-2893.2009.01117.x.","journal-title":"J Viral Hepat"},{"key":"4714_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/hepr.13277","volume":"49","author":"Y Suzuki","year":"2019","unstructured":"Suzuki Y, Maekawa S, Komatsu N, Sato M, Tatsumi A, Miura M, et al. Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core\u2010related antigen titers have a high risk of HBV\u2010related hepatocellular carcinoma. Hepatol Res. 2019;49:51\u201363. https:\/\/doi.org\/10.1111\/hepr.13277.","journal-title":"Hepatol Res"},{"key":"4714_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/v14010082","volume":"14","author":"MW Sonderup","year":"2022","unstructured":"Sonderup MW, Spearman CW. Global disparities in hepatitis B elimination\u2014a focus on Africa. Viruses. 2022;14:82. https:\/\/doi.org\/10.3390\/v14010082.","journal-title":"Viruses"},{"key":"4714_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","volume":"11","author":"D Lavanchy","year":"2004","unstructured":"Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97\u2013107. https:\/\/doi.org\/10.1046\/j.1365-2893.2003.00487.x.","journal-title":"J Viral Hepat"},{"key":"4714_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/jmv.20320","volume":"76","author":"Y Suzuki","year":"2005","unstructured":"Suzuki Y, Kobayashi M, Ikeda K, Suzuki F, Arfase Y, Akuta N, et al. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan. J Med Virol. 2005;76:33\u20139. https:\/\/doi.org\/10.1002\/jmv.20320.","journal-title":"J Med Virol"},{"key":"4714_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-2893.2005.00584.x","volume":"12","author":"S Schaefer","year":"2005","unstructured":"Schaefer S. Hepatitis B virus: significance of genotypes. J Viral Hepat. 2005;12:111\u201324. https:\/\/doi.org\/10.1111\/j.1365-2893.2005.00584.x.","journal-title":"J Viral Hepat"},{"key":"4714_CR11","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/S0140-6736(18)31865-8","volume":"392","author":"W-K Seto","year":"2018","unstructured":"Seto W-K, Lo Y-R, Pawlotsky J-M, Yuen M-F. Chronic hepatitis B virus infection. Lancet. 2018;392:2313\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(18)31865-8.","journal-title":"Lancet"},{"key":"4714_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-5575-6","volume":"18","author":"S Tosun","year":"2018","unstructured":"Tosun S, Ayg\u00fcn O, \u00d6zdemir H\u00d6, Korkmaz E, \u00d6zdemir D. The impact of economic and social factors on the prevalence of hepatitis B in Turkey. BMC Public Health. 2018;18:649. https:\/\/doi.org\/10.1186\/s12889-018-5575-6.","journal-title":"BMC Public Health"},{"key":"4714_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00696","volume":"10","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Wang C, Liu Z, Zou G, Li J, Lu M. Host genetic determinants of hepatitis B virus infection. Front Genet. 2019;10:696. https:\/\/doi.org\/10.3389\/fgene.2019.00696.","journal-title":"Front Genet"},{"key":"4714_CR14","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1016\/j.jhep.2023.06.014","volume":"80","author":"M-C Guan","year":"2024","unstructured":"Guan M-C, Ding Q, Zhu H. Which risk model can better predict hepatocellular carcinoma in hepatitis B patients with an antiviral treatment duration of over 1 year? J Hepatol. 2024;80:e160. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.014.","journal-title":"J Hepatol"},{"key":"4714_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11664","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Si L, Zhai Y, Hu Y, Hu Z, Bei J-X, et al. Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese. Nat Commun. 2016;7:11664. https:\/\/doi.org\/10.1038\/ncomms11664.","journal-title":"Nat Commun"},{"key":"4714_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-981-15-1045-8_5","volume-title":"Dyn. Immune Act. Viral dis","author":"P Sanapala","year":"2020","unstructured":"Sanapala P, Pola S. Role of cytokines in infectious viral disease. In: Bramhachari PV, editor. Dyn. Immune Act. Viral dis. Singapore: Springer; 2020. pp. 81\u201398. https:\/\/doi.org\/10.1007\/978-981-15-1045-8_5."},{"key":"4714_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/j.1365-2893.2007.00880.x","volume":"14","author":"P Kummee","year":"2007","unstructured":"Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat. 2007;14:841\u20138. https:\/\/doi.org\/10.1111\/j.1365-2893.2007.00880.x.","journal-title":"J Viral Hepat"},{"key":"4714_CR18","first-page":"28","volume":"6","author":"H Rahbar Kafshboran","year":"2014","unstructured":"Rahbar Kafshboran H, Bonyadi M, Miri H, Haghi M, Nikravesh A, Abdolmohammadi R, et al. Association of TNF-\u03b1 -857 polymorphism with inflammatory bowel disease in a group of Iranian Azeri individuals. Middle East J Dig Dis. 2014;6:28\u201331.","journal-title":"Middle East J Dig Dis"},{"key":"4714_CR19","unstructured":"Haywood L. Tumor necrosis factor alpha. J Natl Med Assoc 1998. https:\/\/pubmed.ncbi.nlm.nih.gov\/9549973\/"},{"key":"4714_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","volume":"12","author":"GD Kalliolias","year":"2016","unstructured":"Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12:49\u201362. https:\/\/doi.org\/10.1038\/nrrheum.2015.169.","journal-title":"Nat Rev Rheumatol"},{"key":"4714_CR21","doi-asserted-by":"publisher","unstructured":"El Hachimi H, El Alem MMM, Haimoudane E, Yebouk C, Pedersen J, Fall-Malick F-Z, et al. The first assessments of pediatric HBV immunization coverage in Mauritania and persistence of antibody titers post infant immunizations. Vaccines. 2023;11:588. . https:\/\/doi.org\/10.3390\/vaccines11030588","DOI":"10.3390\/vaccines11030588"},{"key":"4714_CR22","doi-asserted-by":"publisher","unstructured":"Boushab BM, Mela\u00efnine Mohamed Limame OC, Zahra F-MF, Mamoudou S, Roseline Darnycka BM, Saliou SM. Estimation of Seroprevalence of HIV, hepatitis B and C virus and syphilis among blood donors in the hospital of A\u00efoun, Mauritania. Pan Afr Med J 2017;28. https:\/\/doi.org\/10.11604\/pamj.2017.28.118.12465","DOI":"10.11604\/pamj.2017.28.118.12465"},{"key":"4714_CR23","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.vaccine.2021.03.011","volume":"39","author":"A El Bara","year":"2021","unstructured":"El Bara A, Pivert A, Veillon P, Ng Wing Sang C, Bollahi M, Abdel K, et al. From national HBV and HDV screenings to vaccination and treatment in healthcare workers: the Mauritanian pilot study. Vaccine. 2021;39:2274\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.011.","journal-title":"Vaccine"},{"key":"4714_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcv.2012.05.011","volume":"55","author":"W Mansour","year":"2012","unstructured":"Mansour W, Bollahi M-A, Hamed C-T, Brichler S, Le Gal F, Ducancelle A, et al. Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott, Mauritania. J Clin Virol. 2012;55:12\u20136. https:\/\/doi.org\/10.1016\/j.jcv.2012.05.011.","journal-title":"J Clin Virol"},{"key":"4714_CR25","doi-asserted-by":"publisher","unstructured":"Metcalfe C. Biostatistics: a foundation for analysis in the health sciences. 7th edn. Wayne W. Daniel, Wiley, 1999. No. of. pages: xiv\u2009+\u2009755\u2009+\u2009appendices. Price: \u00a328.95. ISBN 0-471-16386-4. Stat Med. 2001;20:324\u20136. https:\/\/doi.org\/10.1002\/1097-0258(20010130)20:2%253C324::AID-SIM635%253E3.0.CO;2-O .","DOI":"10.1002\/1097-0258(20010130)20:2%253C324::AID-SIM635%253E3.0.CO;2-O"},{"key":"4714_CR26","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/jmv.23336","volume":"84","author":"W Mansour","year":"2012","unstructured":"Mansour W, Malick F-ZF, Sidiya A, Ishagh E, Chekaraou MA, Veillon P, et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J Med Virol. 2012;84:1186\u201398. https:\/\/doi.org\/10.1002\/jmv.23336.","journal-title":"J Med Virol"},{"key":"4714_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09503-w","volume":"24","author":"T Soumbara","year":"2024","unstructured":"Soumbara T, Bonnet C, Hamed CT, Veten F, Hemeyine M, Fall-Malick F-Z, et al. Genetic variation of TLR3 gene is associated with the outcome of hepatitis b infection in Mauritanian patients: case control study. BMC Infect Dis. 2024;24:616. https:\/\/doi.org\/10.1186\/s12879-024-09503-w.","journal-title":"BMC Infect Dis"},{"key":"4714_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"P Lampertico","year":"2017","unstructured":"Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370\u201398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021.","journal-title":"J Hepatol"},{"key":"4714_CR29","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2893.2006.00731.x","volume":"13","author":"T Du","year":"2006","unstructured":"Du T, Guo X-H, Zhu X, \u2010L., Li J, \u2010H., Lu L, \u2010P., Gao J\u2010R, et al. Association of TNF\u2010alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population. J Viral Hepat. 2006;13:618\u201324. https:\/\/doi.org\/10.1111\/j.1365-2893.2006.00731.x.","journal-title":"J Viral Hepat"},{"key":"4714_CR30","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/gast.2001.24839","volume":"120","author":"AS Lok","year":"2001","unstructured":"Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000\u2014summary of a workshop. Gastroenterology. 2001;120:1828\u201353. https:\/\/doi.org\/10.1053\/gast.2001.24839.","journal-title":"Gastroenterology"},{"key":"4714_CR31","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1053\/j.gastro.2013.04.028","volume":"144","author":"F Zoulim","year":"2013","unstructured":"Zoulim F, Luangsay S, Durantel D. Targeting innate immunity: a new step in the development of combination therapy for chronic hepatitis B. Gastroenterology. 2013;144:1342\u20134. https:\/\/doi.org\/10.1053\/j.gastro.2013.04.028.","journal-title":"Gastroenterology"},{"key":"4714_CR32","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1136\/jcp.47.12.1112","volume":"47","author":"MJ Hussain","year":"1994","unstructured":"Hussain MJ, Lau JY, Williams R, Vergani D. Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection. J Clin Pathol. 1994;47:1112\u20135. https:\/\/doi.org\/10.1136\/jcp.47.12.1112.","journal-title":"J Clin Pathol"},{"key":"4714_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103008","volume":"9","author":"H-T Tzeng","year":"2014","unstructured":"Tzeng H-T, Tsai H-F, Chyuan I-T, Liao H-J, Chen C-J, Chen P-J, et al. Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model. PLOS ONE. 2014;9:e103008. https:\/\/doi.org\/10.1371\/journal.pone.0103008.","journal-title":"PLOS ONE"},{"key":"4714_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbadis.2009.01.007","volume":"1792","author":"MM Elahi","year":"2009","unstructured":"Elahi MM, Asotra K, Matata BM, Mastana SS. Tumor necrosis factor alpha\u2009\u2212\u2009308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2009;1792:163\u201372. https:\/\/doi.org\/10.1016\/j.bbadis.2009.01.007.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"4714_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-235","volume":"9","author":"G Cui","year":"2012","unstructured":"Cui G, Wang H, Li R, Zhang L, Li Z, Wang Y, et al. Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. J Neuroinflammation. 2012;9:235. https:\/\/doi.org\/10.1186\/1742-2094-9-235.","journal-title":"J Neuroinflammation"},{"key":"4714_CR36","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/hmg\/ddg262","volume":"12","author":"YJ Kim","year":"2003","unstructured":"Kim YJ, Lee H-S, Yoon J-H, Kim CY, Park MH, Kim LH, et al. Association of TNF -\u03b1 promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet. 2003;12:2541\u20136. https:\/\/doi.org\/10.1093\/hmg\/ddg262.","journal-title":"Hum Mol Genet"},{"key":"4714_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.gene.2015.05.029","volume":"568","author":"I Sghaier","year":"2015","unstructured":"Sghaier I, Zidi S, Mouelhi L, Dabbech R, Ghazouani E, Brochot E, et al. The relationship between TNF alpha gene polymorphisms (\u2212\u2009238\/\u2212308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population. Gene. 2015;568:140\u20135. https:\/\/doi.org\/10.1016\/j.gene.2015.05.029.","journal-title":"Gene"},{"key":"4714_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.humimm.2017.10.006","volume":"78","author":"RM Talaat","year":"2017","unstructured":"Talaat RM, Abdelkhalek MS, El-Maadawy EA, Abdel-Mageed WS, El-Shenawy SZ, Osman MA. Association of TNF-Alpha gene polymorphisms and susceptibility to hepatitis B virus infection in Egyptians. Hum Immunol. 2017;78:739\u201346. https:\/\/doi.org\/10.1016\/j.humimm.2017.10.006.","journal-title":"Hum Immunol"},{"key":"4714_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019606","volume":"6","author":"Q Xia","year":"2011","unstructured":"Xia Q, Zhou L, Liu D, Chen Z, Chen F. Relationship between TNF- gene promoter polymorphisms and outcomes of hepatitis B virus infections: a meta-analysis. PLoS ONE. 2011;6:e19606. https:\/\/doi.org\/10.1371\/journal.pone.0019606.","journal-title":"PLoS ONE"},{"key":"4714_CR40","doi-asserted-by":"publisher","DOI":"10.1017\/S095026882300050X","volume":"151","author":"N Riches","year":"2023","unstructured":"Riches N, Vinikoor M, Guingane A, Johannessen A, Lemoine M, Matthews P, et al. Hepatitis B in Africa collaborative network: cohort profile and analysis of baseline data. Epidemiol Infect. 2023;151:e65. https:\/\/doi.org\/10.1017\/S095026882300050X.","journal-title":"Epidemiol Infect"},{"key":"4714_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100593","volume":"4","author":"S Chevaliez","year":"2022","unstructured":"Chevaliez S, Roudot-Thoraval F, Brouard C, Gordien E, Zoulim F, Brichler S, et al. Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008\u20132012: a cross-sectional study. JHEP Rep. 2022;4:100593. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100593.","journal-title":"JHEP Rep"},{"key":"4714_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2015.30","volume":"4","author":"Z Li","year":"2015","unstructured":"Li Z, Hou X, Cao G. Is mother-to-infant transmission the most important factor for persistent HBV infection? Emerg Microbes Infect. 2015;4:1\u20139. https:\/\/doi.org\/10.1038\/emi.2015.30.","journal-title":"Emerg Microbes Infect"},{"key":"4714_CR43","first-page":"3381","volume":"17","author":"SS Azar","year":"2016","unstructured":"Azar SS, Mansoori M, Attar M, Shahbazi M. Tumor necrosis factor alpha 308 G\/A single nucleotide polymorphism and susceptibility to hepatocellular carcinoma via hepatitis B infection. Asian Pac J Cancer Prev APJCP. 2016;17:3381\u20134.","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"4714_CR44","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1128\/JVI.66.6.3955-3960.1992","volume":"66","author":"PN Gilles","year":"1992","unstructured":"Gilles PN, Fey G, Chisari FV. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J Virol. 1992;66:3955\u201360. https:\/\/doi.org\/10.1128\/JVI.66.6.3955-3960.1992.","journal-title":"J Virol"},{"key":"4714_CR45","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.23226","volume":"50","author":"M H\u00f6sel","year":"2009","unstructured":"H\u00f6sel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, Broxtermann M, et al. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology. 2009;50:1773\u201382. https:\/\/doi.org\/10.1002\/hep.23226.","journal-title":"Hepatology"},{"key":"4714_CR46","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/jmv.24225","volume":"87","author":"SdaC Ferreira","year":"2015","unstructured":"Ferreira SdaC, Chach\u00e1 SGF, Souza FF, Teixeira AC, de Carvalho Santana R, Deghaide NHS, et al. IL-18, TNF, and IFN-\u03b3 alleles and genotypes are associated with susceptibility to chronic hepatitis B infection and severity of liver injury. J Med Virol. 2015;87:1689\u201396. https:\/\/doi.org\/10.1002\/jmv.24225.","journal-title":"J Med Virol"},{"key":"4714_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005609","volume":"95","author":"Q Xiao","year":"2016","unstructured":"Xiao Q, Fu B, Chen P, Liu ZZ, Wang W, Ye Q. Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: a meta-analysis. Medicine (Baltimore). 2016;95:e5609. https:\/\/doi.org\/10.1097\/MD.0000000000005609.","journal-title":"Medicine (Baltimore)"},{"key":"4714_CR48","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cyto.2010.11.018","volume":"53","author":"S Helmig","year":"2011","unstructured":"Helmig S, Aliahmadi N, Stephan P, D\u00f6hrel J, Schneider J. TNF-\u03b1\u2009\u2212\u2009308 genotypes are associated with TNF-\u03b1 and TGF-\u03b21 mRNA expression in blood leucocytes of humans. Cytokine. 2011;53:306\u201310. https:\/\/doi.org\/10.1016\/j.cyto.2010.11.018.","journal-title":"Cytokine"},{"key":"4714_CR49","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2310\/JIM.0b013e318189152b","volume":"56","author":"E Oreg\u00f3n-Romero","year":"2008","unstructured":"Oreg\u00f3n-Romero E, V\u00e1zquez-Del Mercado M, Ruiz-Quezada SL, Navarro-Hern\u00e1ndez RE, Rangel-Villalobos H, Mart\u00ednez-Bonilla G, et al. Tumor Necrosis Factor \u03b1-308 and \u2212\u2009238 Polymorphisms in Rheumatoid Arthritis. Association with Messenger RNA Expression and sTNF-\u03b1. J Investig Med. 2008;56:937\u201343. https:\/\/doi.org\/10.2310\/JIM.0b013e318189152b.","journal-title":"J Investig Med"},{"key":"4714_CR50","doi-asserted-by":"publisher","unstructured":"Heidari Z, Moudi B, Mahmoudzadeh Sagheb H, Moudi M. Association of TNF-\u03b1 gene polymorphisms with production of protein and susceptibility to chronic hepatitis B infection in the South East Iranian population. Hepat Mon. 2016;16. https:\/\/doi.org\/10.5812\/hepatmon.41984.","DOI":"10.5812\/hepatmon.41984"},{"key":"4714_CR51","unstructured":"Li H-Q, Li Z, Liu Y, Li J-H, Dong J-Q, Gao J-R et al. Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection n.d."},{"key":"4714_CR52","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1111\/j.1365-2893.2011.01540.x","volume":"19","author":"K-Q Shi","year":"2012","unstructured":"Shi K-Q, Cai X-H, Xiao D-D, Wu S-J, Peng M-M, Lin X-F, et al. Tumour necrosis factor-\u03b1-857T allele reduces the risk of hepatitis B virus infection in an Asian population. J Viral Hepat. 2012;19:e66\u201372. https:\/\/doi.org\/10.1111\/j.1365-2893.2011.01540.x.","journal-title":"J Viral Hepat"},{"key":"4714_CR53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/00365529850166185","volume":"33","author":"Y Horie","year":"1998","unstructured":"Horie Y, Chiba M, Suzuki T, Kudo T, Kamata A, Iizuka M, et al. Induction of major histocompatibility complex class II antigens on human colonic epithelium by interferon-gamma, tumor necrosis factor-alpha, and interleukin-2. J Gastroenterol. 1998;33:39\u201347. https:\/\/doi.org\/10.1080\/00365529850166185.","journal-title":"J Gastroenterol"},{"key":"4714_CR54","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/infdis\/jiq122","volume":"203","author":"B Julg","year":"2011","unstructured":"Julg B, Moodley ES, Qi Y, Ramduth D, Reddy S, Mncube Z, et al. Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection. J Infect Dis. 2011;203:803\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiq122.","journal-title":"J Infect Dis"},{"key":"4714_CR55","first-page":"316","volume":"17","author":"G Scotto","year":"2003","unstructured":"Scotto G, Fazio V, D\u2019Alessandro G, Monno L, Saracino A, Palumbo E, et al. Association between HLA class II antigens and hepatitis C virus infection. J Biol Regul Homeost Agents. 2003;17:316\u201321.","journal-title":"J Biol Regul Homeost Agents"},{"key":"4714_CR56","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1097\/MCG.0000000000000261","volume":"49","author":"Y-J Jin","year":"2015","unstructured":"Jin Y-J, Lee D, Chung Y-H, Kim JA, Kim SE, Lee Y-S, et al. Tumor necrosis Factor-Alpha gene polymorphism associated with development of hepatitis B Virus\u2013associated hepatocellular carcinoma. J Clin Gastroenterol. 2015;49:e76\u201381. https:\/\/doi.org\/10.1097\/MCG.0000000000000261.","journal-title":"J Clin Gastroenterol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-04714-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:58:21Z","timestamp":1772186301000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-04714-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4714"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-04714-4","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study adhered to the Declaration of Hel\u00acsinki and received approval from the University of Nouakchott\u2019s Ethics Com\u00acmittee (ethics clearance letter No002\/2020\/CE\/UNA), on behalf of the Health Ministry. All Participants provided informed consent at the time of inclusion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}